Pharmacological Methods of Pain Management: Narrative Review of Medication Used

References

• Raja SN, Carr DB, Cohen M, et al. The revised IASP definition of pain: concepts, challenges, and compromises. Pain. 2020;161:1976. doi:10.1097/J.PAIN.0000000000001939
   PubMed Web of Science ®Google Scholar
• Pinho-Ribeiro FA, Verri WA, Chiu IM. Nociceptor sensory neuron–immune interactions in pain and inflammation. Trends Immunol. 2017;38:5–19. doi:10.1016/J.IT.2016.10.001
   PubMed Web of Science ®Google Scholar
• Steeds CE. The anatomy and physiology of pain. Surg. 2009;27:507–511. doi:10.1016/J.MPSUR.2009.10.013
   Google Scholar
• Katz N. The impact of pain management on quality of life. J Pain Symptom Manage. 2002;24:S38–S47. doi:10.1016/S0885-3924(02)00411-6
   PubMed Web of Science ®Google Scholar
• Deshpande MA, Holden RR, Gilron I. The impact of therapy on quality of life and mood in neuropathic pain: what is the effect of pain reduction? Anesth Analg. 2006;102:1473–1479. doi:10.1213/01.ANE.0000204295.90178.77
   PubMed Web of Science ®Google Scholar
• Yam MF, Loh YC, Tan CS, Adam SK, Manan NA, Basir R. General pathways of pain sensation and the major neurotransmitters involved in pain regulation. Int J Mol Sci. 2018;19:2164. doi:10.3390/IJMS19082164
   PubMed Web of Science ®Google Scholar
• Dubin AE, Patapoutian A. Nociceptors: the sensors of the pain pathway. J Clin Invest. 2010;120:3760–3772. doi:10.1172/JCI42843
   PubMed Web of Science ®Google Scholar
• Ohashi N, Kohno T. Analgesic effect of acetaminophen: a review of known and novel mechanisms of action. Front Pharmacol. 2020;11:1916. doi:10.3389/FPHAR.2020.580289/BIBTEX
   Web of Science ®Google Scholar
• Chen R, Coppes OJM, Urman RD. Receptor and molecular targets for the development of novel opioid and non-opioid analgesic therapies. Pain Physician. 2021;24:153–163. doi:10.36076/ppj.2021.24.153-163
   PubMed Web of Science ®Google Scholar
• Zieglgänsberger W. Substance P and pain chronicity. Cell Tissue Res. 2018;375:227–241. doi:10.1007/S00441-018-2922-Y
   PubMed Web of Science ®Google Scholar
• Ahmad AH, Abdul Aziz CB. The brain in pain. Malays J Med Sci. 2014;21:46. doi:10.1097/01.bonej.0000265758.09846.32
   PubMedGoogle Scholar
• Hill RG. Molecular basis for the perception of pain. Neuroscientist. 2001;7:282–292. doi:10.1177/107385840100700405
   PubMed Web of Science ®Google Scholar
• Ma RS, Kayani K, Whyte-Oshodi D, et al. Voltage gated sodium channels as therapeutic targets for chronic pain. J Pain Res. 2019;12:2709. doi:10.2147/JPR.S207610
   PubMed Web of Science ®Google Scholar
• Park JF, Luo ZD. Calcium channel functions in pain processing. Channels. 2010;4:510. doi:10.4161/CHAN.4.6.12869
   PubMed Web of Science ®Google Scholar
• Schaible HG, Richter F. Pathophysiology of pain. Langenbeck’s Arch Surg. 2004;389:237–243. doi:10.1007/S00423-004-0468-9/METRICS
   PubMed Web of Science ®Google Scholar
• Scherrmann J-M, Wolff K, Franco CA, et al. Allodynia. Encycl Psychopharmacol. 2022:65. doi:10.1007/978-3-540-68706-1_1043
   Google Scholar
• Andronis L, Kinghorn P, Qiao S, Whitehurst DGT, Durrell S, McLeod H. Cost-effectiveness of non-invasive and non-pharmacological interventions for low back pain: a systematic literature review. Appl Health Econ Health Policy. 2017;15:173–201. doi:10.1007/S40258-016-0268-8/TABLES/3
   PubMed Web of Science ®Google Scholar
• Moisset X, Bouhassira D, Avez Couturier J, et al. Pharmacological and non-pharmacological treatments for neuropathic pain: systematic review and French recommendations. Rev Neurol. 2020;176:325–352. doi:10.1016/J.NEUROL.2020.01.361
   PubMedGoogle Scholar
• Dharmshaktu P, Tayal V, Kalra BS. Efficacy of antidepressants as analgesics: a review. J Clin Pharmacol. 2012;52:6–17. doi:10.1177/0091270010394852
   PubMed Web of Science ®Google Scholar
• Vyvey M. Steroids as pain relief adjuvants. Can Fam Physician. 2010;56:1295.
   PubMed Web of Science ®Google Scholar
• Yu K, Niu X, He B, Yu K, Niu X, He B. Neuromodulation management of chronic neuropathic pain in the central nervous system. Adv Funct Mater. 2020;30:1908999. doi:10.1002/ADFM.201908999
   PubMed Web of Science ®Google Scholar
• Knotkova H, Hamani C, Sivanesan E, et al. Neuromodulation for chronic pain. Lancet. 2021;397:2111–2124. doi:10.1016/S0140-6736(21)00794-7
   PubMed Web of Science ®Google Scholar
• Fink R. Pain assessment: the cornerstone to optimal pain management. Proc. 2000;13:236. doi:10.1080/08998280.2000.11927681
   Google Scholar
• Alorfi NM. Prescribing patterns and pharmacological knowledge of analgesics among community pharmacists in Jeddah, Saudi Arabia. Bull Pharm Sci Assiut. 2023;46:647–657. doi:10.21608/BFSA.2023.301293
   Google Scholar
• Kim KH, Seo HJ, Abdi S, Huh B. All about pain pharmacology: what pain physicians should know. Korean J Pain. 2020;33:108. doi:10.3344/KJP.2020.33.2.108
   PubMed Web of Science ®Google Scholar
• Mullins S, Hosseini F, Gibson W, Thake M. Physiological changes from ageing regarding pain perception and its impact on pain management for older adults. Clin Med. 2022;22:307. doi:10.7861/CLINMED.22.4.PHYS
   PubMed Web of Science ®Google Scholar
• Yong RJ, Mullins PM, Bhattacharyya N. Prevalence of chronic pain among adults in the United States. Pain. 2022;163:E328–E332. doi:10.1097/J.PAIN.0000000000002291
   PubMed Web of Science ®Google Scholar
• Alorfi NM, Alqurashi RS, Algarni AS. Assessment of community pharmacists’ knowledge about drug-drug interactions in Jeddah, Saudi Arabia. Front Pharmacol. 2023;14. doi:10.3389/FPHAR.2023.1209318
   Web of Science ®Google Scholar
• Alorfi NM, Ashour AM, Algarni AS, Alsolami FA, Alansari AM, Tobaiqy M. Assessment of the community pharmacists’ knowledge and attitudes toward pain and pain management in Saudi Arabia. Int J Gen Med. 2022;15:8527–8537. doi:10.2147/IJGM.S387066
   PubMed Web of Science ®Google Scholar
• Alorfi NM. Pharmacological treatments of fibromyalgia in adults; overview of Phase IV clinical trials. Front Pharmacol. 2022;13. doi:10.3389/FPHAR.2022.1017129
   Web of Science ®Google Scholar
• Schug SA, Robert Garrett W, Gillespie G. Opioid and non-opioid analgesics. Best Pract Res Clin Anaesthesiol. 2003;17:91–110. doi:10.1053/BEAN.2003.0267
   PubMedGoogle Scholar
• Ghlichloo I, Gerriets V. Nonsteroidal Anti-inflammatory Drugs (NSAIDs). In: Treatment of Chronic Pain Conditions: A Comprehensive Handbook. springer; 2023:77–79. doi:10.1007/978-1-4939-6976-0_21
   Google Scholar
• Pountos I, Georgouli T, Bird H, Giannoudis PV. Nonsteroidal anti-inflammatory drugs: prostaglandins, indications, and side effects. Int J Interf Cytokine Mediat Res. 2011;3:19–27. doi:10.2147/IJICMR.S10200
   Google Scholar
• Green GA. Understanding NSAIDs: from aspirin to COX-2. Clin Cornerstone. 2001;3:50–59. doi:10.1016/S1098-3597(01)90069-9
   PubMedGoogle Scholar
• Labianca R, Sarzi-Puttini P, Zuccaro SM, Cherubino P, Vellucci R, Fornasari D. Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain. Clin Drug Investig. 2012;32:53–63. doi:10.2165/11630080-000000000-00000/METRICS
   Web of Science ®Google Scholar
• Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res. 2003;110:255–258. doi:10.1016/S0049-3848(03)00379-7
   PubMed Web of Science ®Google Scholar
• Risser A, Donovan D, Heintzman J, Page T. NSAID prescribing precautions. Am Fam Physician. 2009;80:1371–1378.
   PubMed Web of Science ®Google Scholar
• Blough ER, Wu M. Acetaminophen: beyond pain and fever-relieving. Front Pharmacol. 2011;2:72. doi:10.3389/FPHAR.2011.00072/BIBTEX
   PubMed Web of Science ®Google Scholar
• Botting RM. Mechanism of action of acetaminophen: is there a cyclooxygenase 3? Clin Infect Dis. 2000;31:S202–S210. doi:10.1086/317520
   PubMed Web of Science ®Google Scholar
• Serda M, Becker FG, Cleary M, et al. Acetaminophen (paracetamol): properties, clinical uses, and adverse effects. Uniw Slaski. 2012;7:1–24.
   Google Scholar
• Sawynok J. Topical analgesics in neuropathic pain. Curr Pharm Des. 2005;11:2995–3004. doi:10.2174/1381612054865019
   PubMed Web of Science ®Google Scholar
• Stanos SP, Galluzzi KE. Topical therapies in the management of chronic pain. Postgrad Med. 2013;125(sup1):25–33. doi:10.1080/00325481.2013.1110567111
   PubMedGoogle Scholar
• Hamza M, Dionne RA. Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition. Curr Mol Pharmacol. 2009;2:1. doi:10.2174/1874467210902010001
   PubMedGoogle Scholar
• Langford RM. Pain management today—what have we learned? Clin Rheumatol. 2006;25:2–8. doi:10.1007/S10067-006-0311-5
   PubMed Web of Science ®Google Scholar
• Argoff CE. Topical analgesics in the management of acute and chronic pain. Mayo Clin Proc. 2013;88:195–205. doi:10.1016/J.MAYOCP.2012.11.015
   PubMed Web of Science ®Google Scholar
• Díaz-González F, Sánchez-Madrid F. NSAIDs: learning new tricks from old drugs. Eur J Immunol. 2015;45:679. doi:10.1002/EJI.201445222
   PubMed Web of Science ®Google Scholar
• Ziccardi P, Nappo F, Giugliano G, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation. 2002;105:804–809. doi:10.1161/hc0702.104279
   PubMed Web of Science ®Google Scholar
• Bacchi S, Palumbo P, Sponta A, Coppolino MF. Clinical pharmacology of non-steroidal anti-inflammatory drugs: a review. Antiinflamm Antiallergy Agents Med Chem. 2012;11:52–64. doi:10.2174/187152312803476255
   PubMedGoogle Scholar
• Marsico F, Paolillo S, Filardi PP. NSAIDs and cardiovascular risk. J Cardiovasc Med. 2017;18:e40–e43. doi:10.2459/JCM.0000000000000443
   Google Scholar
• Ramachandran A, Jaeschke H. Acetaminophen hepatotoxicity. Semin Liver Dis. 2019;39:221–234. doi:10.1055/S-0039-1679919/ID/JR1800073-44
   PubMed Web of Science ®Google Scholar
• Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54:1–15. doi:10.1016/J.JAAD.2005.01.010
   PubMed Web of Science ®Google Scholar
• Paul AK, Smith CM, Rahmatullah M, et al. Opioid analgesia and opioid-induced adverse effects: a review. Pharm. 2021;14:1091. doi:10.3390/PH14111091
   Google Scholar
• Kotlińska-Lemieszek A, Żylicz Z. Less well-known consequences of the long-term use of opioid analgesics: a comprehensive literature review. Drug Des Devel Ther. 2022;16:251–264. doi:10.2147/DDDT.S342409
   PubMed Web of Science ®Google Scholar
• Wood E, Solomon ED, Hadland SE. Universal precautions for people at risk of opioid overdose in North America. JAMA Intern Med. 2023;183(5):401. doi:10.1055/s-0039-1679919
   PubMed Web of Science ®Google Scholar
• Inoue K, Nomura M. The neuropathology of drug addictions and substance misuse: assays for fentanyl. In: Neuropathology of Drug Addictions and Substance Misuse. Vol. 3. Academic Press; 2016:619–630. doi:10.1016/B978-0-12-800634-4.00063-9
   Google Scholar
• Trescot AM, Datta S, Lee M, Hans H. Opioid pharmacology. Pain Physician. 2008;11(3;2s):S133–S153. doi:10.36076/ppj.2008/11/s133
   PubMedGoogle Scholar
• Alshehri FS, Alghamdi BS, Hakami AY, Alshehri AA, Althobaiti YS. Melatonin attenuates morphine-induced conditioned place preference in Wistar rats. Brain Behav. 2021;11(12):e2397. doi:10.1002/BRB3.2397
   PubMed Web of Science ®Google Scholar
• Kerrigan S, Goldberger BA. Opioids. In: Princ Forensic Toxicol. Fifth ed. Springer; 2020:347–369. doi:10.1007/978-3-030-42917-1_22/FIGURES/5
   Google Scholar
• Skolnick P. Treatment of overdose in the synthetic opioid era. Pharmacol Ther. 2022;233:108019. doi:10.1016/J.PHARMTHERA.2021.108019
   PubMed Web of Science ®Google Scholar
• Valentino RJ, Volkow ND. Untangling the complexity of opioid receptor function. Neuropsychopharmacol. 2018;43(13):2514–2520. doi:10.1038/s41386-018-0225-3
   PubMed Web of Science ®Google Scholar
• Parsells Kelly J, Cook SF, Kaufman DW, Anderson T, Rosenberg L, Mitchell AA. Prevalence and characteristics of opioid use in the US adult population. Pain. 2008;138(3):507–513. doi:10.1016/J.PAIN.2008.01.027
   PubMed Web of Science ®Google Scholar
• Sobanski P, Krajnik M, Shaqura M, Bloch-Boguslawska E, Schäfer M, Mousa SA. The presence of mu-, delta-, and kappa-opioid receptors in human heart tissue. Heart Vessels. 2014;29:855–863. doi:10.1007/S00380-013-0456-5/FIGURES/5
   PubMed Web of Science ®Google Scholar
• Vanderah TW. Delta and kappa opioid receptors as suitable drug targets for pain. Clin J Pain. 2010;26(Supplement 10):S10–S15. doi:10.1097/AJP.0B013E3181C49E3A
   PubMedGoogle Scholar
• Leibovici BL. Medical prescription in the context of drug prohibition: the example of opiates. In: Living with Drugs. Elsevier; 2020:295–303. doi:10.1016/B978-1-78548-317-2.50021-0
   Google Scholar
• Smith H, Bruckenthal P. Implications of opioid analgesia for medically complicated patients. Drugs Aging. 2012;27:417–433. doi:10.2165/11536540-000000000-00000
   Web of Science ®Google Scholar
• Stephan BC, Parsa FD. Avoiding opioids and their harmful side effects in the postoperative patient: exogenous opioids, endogenous endorphins, wellness, mood, and their relation to postoperative pain. Hawaii J Med Public Health. 2016;75:63.
   PubMedGoogle Scholar
• Machelska H, Celik M. Advances in achieving opioid analgesia without side effects. Front Pharmacol. 2018;9:1388. doi:10.3389/FPHAR.2018.01388/BIBTEX
   PubMed Web of Science ®Google Scholar
• Alshehri FS. Tapentadol: a review of experimental pharmacology studies, clinical trials, and recent findings. Drug Des Devel Ther. 2023;17:851–861. doi:10.2147/DDDT.S402362
   PubMed Web of Science ®Google Scholar
• Pattinson KTS. Opioids and the control of respiration. Br J Anaesth. 2008;100:747–758. doi:10.1093/BJA/AEN094
   PubMed Web of Science ®Google Scholar
• Camilleri M, Lembo A, Katzka DA. Opioids in gastroenterology: treating adverse effects and creating therapeutic benefits. Clin Gastroenterol Hepatol. 2017;15:1338. doi:10.1016/J.CGH.2017.05.014
   PubMed Web of Science ®Google Scholar
• Verhamme KMC, Sturkenboom MCJM, Stricker BHC, Bosch R. Drug-induced urinary retention: incidence, management and prevention. Drug Saf. 2008;31:373–388. doi:10.2165/00002018-200831050-00002
   PubMed Web of Science ®Google Scholar
• Seyfried O, Hester J. Opioids and endocrine dysfunction. Br J Pain. 2012;6:17. doi:10.1177/2049463712438299
   PubMedGoogle Scholar
• Morgan MM, Christie MJ. Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human. Br J Pharmacol. 2011;164:1322. doi:10.1111/J.1476-5381.2011.01335.X
   PubMed Web of Science ®Google Scholar
• Alford DP, Compton P, Samet JH. Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med. 2006;144:127. doi:10.7326/0003-4819-144-2-200601170-00010
   PubMed Web of Science ®Google Scholar
• Wallace MS, Papp A. Opioid Withdrawal. In: Challenging Cases and Complication Management in Pain Medicine. Springer; 2023:15–20. doi:10.1007/978-3-319-60072-7_3
   Google Scholar
• Pergolizzi JV, Raffa RB, Rosenblatt MH. Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: current understanding and approaches to management. J Clin Pharm Ther. 2020;45:892–903. doi:10.1111/JCPT.13114
   PubMed Web of Science ®Google Scholar
• Khan MIA, Walsh D, Brito-Dellan N. Opioid and adjuvant analgesics: compared and contrasted. Am J Hosp Palliat Care. 2011;28:378–383. doi:10.1177/1049909111410298
   PubMed Web of Science ®Google Scholar
• Knotkova H, Pappagallo M. Adjuvant analgesics. Anesthesiol Clin. 2007;25:775–786. doi:10.1016/J.ANCLIN.2007.07.006
   PubMedGoogle Scholar
• Mitra R, Jones S. Adjuvant analgesics in cancer pain: a review. Am J Hosp Palliat Care. 2012;29(1):70–79. doi:10.1177/1049909111413256
   PubMed Web of Science ®Google Scholar
• Micó JA, Ardid D, Berrocoso E, Eschalier A. Antidepressants and pain. Trends Pharmacol Sci. 2006;27:348–354. doi:10.1016/J.TIPS.2006.05.004
   PubMed Web of Science ®Google Scholar
• Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2012. doi:10.1002/14651858.CD008242.PUB2/INFORMATION/EN
   Web of Science ®Google Scholar
• Patetsos E, Horjales-Araujo E. Treating chronic pain with SSRIs: what do we know? Pain Res Manag. 2016;2016:1–17. doi:10.1155/2016/2020915
   Web of Science ®Google Scholar
• Raouf M, Glogowski AJ, Bettinger JJ, Fudin J. Serotonin-norepinephrine reuptake inhibitors and the influence of binding affinity (Ki) on analgesia. J Clin Pharm Ther. 2017;42:513–517. doi:10.1111/JCPT.12534
   PubMed Web of Science ®Google Scholar
• Durkin B, Page C, Glass P. Pregabalin for the treatment of postsurgical pain. Expert Opin Pharmacother. 2010;11(16):2751–2758. doi:10.1517/14656566.2010.526106
   PubMed Web of Science ®Google Scholar
• Argoff CE. The coexistence of neuropathic pain, sleep, and psychiatric disorders: a novel treatment approach. Clin J Pain. 2007;23(1):15–22. doi:10.1097/01.AJP.0000210945.27052.B3
   PubMed Web of Science ®Google Scholar
• Mula M, Pini S, Cassano GB. The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence. J Clin Psychopharmacol. 2007;27(3):263–272. doi:10.1097/JCP.0B013E318059361A
   PubMed Web of Science ®Google Scholar
• Jensen TS. Anticonvulsants in neuropathic pain: rationale and clinical evidence. Eur J Pain. 2002;6(SA):61–68. doi:10.1053/EUJP.2001.0324
   PubMedGoogle Scholar
• Backonja -M-M. Use of anticonvulsants for treatment of neuropathic pain. Neurology. 2002;59(Issue 5, Supplement 2):S14–S17. doi:10.1212/WNL.59.5_SUPPL_2.S14
   PubMed Web of Science ®Google Scholar
• Deer TR, Serafini M, Buchser E, Ferrante FM, Hassenbusch SJ. Intrathecal bupivacaine for chronic pain: a review of current knowledge. Neuromodulation. 2002;5:196–207. doi:10.1046/J.1525-1403.2002.02030.X
   PubMed Web of Science ®Google Scholar
• Yanagidate F, Strichartz GR. Local anesthetics. Handb Exp Pharmacol. 2007;177:95–127. doi:10.1007/978-3-540-33823-9_4
   PubMedGoogle Scholar
• Casale R, Symeonidou Z, Bartolo M. Topical treatments for localized neuropathic pain. Curr Pain Headache Rep. 2017;21:1–9. doi:10.1007/S11916-017-0615-Y/TABLES/1
   PubMed Web of Science ®Google Scholar
• Scholz A. Mechanisms of (local) anaesthetics on voltage-gated sodium and other ion channels. Br J Anaesth. 2002;89(1):52–61. doi:10.1093/bja/aef163
   PubMed Web of Science ®Google Scholar
• Taylor A, McLeod G. Basic pharmacology of local anaesthetics. Br J Anaesth Educ. 2020;20(2):34. doi:10.1016/J.BJAE.2019.10.002
   Google Scholar
• Mazoit JX, Dalens BJ. Pharmacokinetics of local anaesthetics in infants and children. Clin Pharmacokinet. 2004;43:17–32. doi:10.2165/00003088-200443010-00002/FIGURES/5
   PubMed Web of Science ®Google Scholar
• Bucklin BA, Chestnut DH, Hawkins JL. Intrathecal opioids versus epidural local anesthetics for labor analgesia: a meta-analysis. Reg Anesth Pain Med. 2002;27:23–30. doi:10.1053/RAPM.2002.29111
   PubMed Web of Science ®Google Scholar
• Bagshaw KR, Hanenbaum CL, Carbone EJ, et al. Pain management via local anesthetics and responsive hydrogels. Ther Deliv. 2015;6:165. doi:10.4155/TDE.14.95
   PubMed Web of Science ®Google Scholar
• El-Boghdadly K, Pawa A, Chin KJ. Local anesthetic systemic toxicity: current perspectives. Local Reg Anesth. 2018;11:35–44. doi:10.2147/LRA.S154512
   PubMed Web of Science ®Google Scholar
• Dillane D, Finucane BT. Local anesthetic systemic toxicity. Can J Anaesth. 2010;57:368–380. doi:10.1007/S12630-010-9275-7
   PubMed Web of Science ®Google Scholar
• Gitman M, Barrington MJ. Local anesthetic systemic toxicity: a review of recent case reports and registries. Reg Anesth Pain Med. 2018;43:124–130. doi:10.1097/AAP.0000000000000721
   PubMed Web of Science ®Google Scholar
• Coutinho AE, Chapman KE. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol. 2011;335:2. doi:10.1016/J.MCE.2010.04.005
   PubMed Web of Science ®Google Scholar
• Arroll B, Goodyear-Smith F. Corticosteroid injections for osteoarthritis of the knee: meta-analysis. Br Med J. 2004;328(7444):869. doi:10.1136/BMJ.38039.573970.7C
   PubMedGoogle Scholar
• van der Goes MC, Jacobs JW, Bijlsma JW. The value of glucocorticoid co-therapy in different rheumatic diseases - positive and adverse effects. Arthritis Res Ther. 2014;16(Suppl 2):1–13. doi:10.1186/AR4686/FIGURES/3
   Google Scholar
• Wharton S, Raiber L, Serodio KJ, Lee J, Christensen RAG. Medications that cause weight gain and alternatives in Canada: a narrative review. Diabetes Metab Syndr Obes. 2018;11:427–438. doi:10.2147/DMSO.S171365
   PubMed Web of Science ®Google Scholar
• Savas M, Wester VL, Staufenbiel SM, et al. Systematic evaluation of corticosteroid use in obese and non-obese individuals: a Multi-cohort Study. Int J Med Sci. 2017;14:615. doi:10.7150/IJMS.19213
   PubMed Web of Science ®Google Scholar
• Brown ES, Chandler PA. Mood and cognitive changes during systemic corticosteroid therapy. Prim Care Companion J Clin Psychiatry. 2001;3:17. doi:10.4088/PCC.V03N0104
   PubMedGoogle Scholar
• Oray M, Abu Samra K, Ebrahimiadib N, Meese H, Foster CS. Long-term side effects of glucocorticoids. Expert Opin Drug Saf. 2016;15:457–465. doi:10.1517/14740338.2016.1140743
   PubMed Web of Science ®Google Scholar
• Galafassi GZ, Simm Pires de Aguiar PH, Simm RF, et al. Neuromodulation for medically refractory neuropathic pain: spinal cord stimulation, deep brain stimulation, motor cortex stimulation, and posterior insula stimulation. World Neurosurg. 2021;146:246–260. doi:10.1016/J.WNEU.2020.11.048
   PubMed Web of Science ®Google Scholar
• Alamri A, Pereira EAC. Deep brain stimulation for chronic pain. Neurosurg Clin N Am. 2022;33:311–321. doi:10.1016/J.NEC.2022.02.013
   PubMed Web of Science ®Google Scholar
• Johnson MI, Paley CA, Jones G, Mulvey MR, Wittkopf PG. Efficacy and safety of transcutaneous electrical nerve stimulation (TENS) for acute and chronic pain in adults: a systematic review and meta-analysis of 381 studies (the meta-TENS study). BMJ Open. 2022;12. doi:10.1136/BMJOPEN-2021-051073
   Web of Science ®Google Scholar
• Capozza MA, Triarico S, Mastrangelo S, Attinà G, Maurizi P, Ruggiero A. Narrative review of intrathecal drug delivery (IDD): indications, devices and potential complications. Ann Transl Med. 2021;9:186. doi:10.21037/ATM-20-3814
   PubMed Web of Science ®Google Scholar
• George SZ, Goode AP. Physical therapy and opioid use for musculoskeletal pain management: competitors or companions? Pain Rep. 2020;5:E827. doi:10.1097/PR9.0000000000000827
   PubMedGoogle Scholar
• Chimenti RL, Frey-Law LA, Sluka KA, Chimenti RL, Frey-Law LA, Sluka KA. A mechanism-based approach to physical therapist management of pain. Phys Ther. 2018;98:302–314. doi:10.1093/PTJ/PZY030
   PubMed Web of Science ®Google Scholar
• Rakel B, Barr JO. Physical modalities in chronic pain management. Nurs Clin North Am. 2003;38:477–494. doi:10.1016/S0029-6465(02)00097-X
   PubMed Web of Science ®Google Scholar
• Bao S, Qiao M, Lu Y, Jiang Y. Neuroimaging mechanism of cognitive behavioral therapy in pain management. Pain Res Manag. 2022;2022. doi:10.1155/2022/6266619
   Web of Science ®Google Scholar
• Tournaire M, Theau-Yonneau A. Complementary and alternative approaches to pain relief during labor. Evid Based Complement Alternat Med. 2007;4:409–417. doi:10.1093/ECAM/NEM012
   PubMed Web of Science ®Google Scholar
• Singh P, Chaturvedi A. Complementary and alternative medicine in cancer pain management: a systematic review. Indian J Palliat Care. 2015;21:105. doi:10.4103/0973-1075.150202
   PubMedGoogle Scholar
• Hua S, Cabot PJ. PAIN - novel targets and new technologies. Front Pharmacol. 2014;5:111026. doi:10.3389/FPHAR.2014.00211/BIBTEX
   Web of Science ®Google Scholar
• Hone AJ, McIntosh JM. Nicotinic acetylcholine receptors: therapeutic targets for novel ligands to treat pain and inflammation. Pharmacol Res. 2023;190:106715. doi:10.1016/J.PHRS.2023.106715
   PubMed Web of Science ®Google Scholar
• Sharma A, Behl T, Sharma L, et al. Exploring the molecular pathways and therapeutic implications of angiogenesis in neuropathic pain. Biomed Pharmacother. 2023;162:114693. doi:10.1016/J.BIOPHA.2023.114693
   PubMed Web of Science ®Google Scholar